"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Descriptor ID |
D007167
|
MeSH Number(s) |
E02.095.465.425
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in this website by year, and whether "Immunotherapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1996 | 1 | 0 | 1 |
1998 | 0 | 3 | 3 |
1999 | 2 | 1 | 3 |
2000 | 3 | 2 | 5 |
2001 | 2 | 5 | 7 |
2002 | 2 | 3 | 5 |
2003 | 2 | 4 | 6 |
2004 | 5 | 8 | 13 |
2005 | 3 | 2 | 5 |
2006 | 4 | 2 | 6 |
2007 | 4 | 1 | 5 |
2008 | 7 | 6 | 13 |
2009 | 4 | 2 | 6 |
2010 | 7 | 5 | 12 |
2011 | 5 | 5 | 10 |
2012 | 8 | 7 | 15 |
2013 | 8 | 9 | 17 |
2014 | 8 | 8 | 16 |
2015 | 9 | 15 | 24 |
2016 | 20 | 2 | 22 |
2017 | 22 | 3 | 25 |
2018 | 29 | 14 | 43 |
2019 | 29 | 16 | 45 |
2020 | 19 | 25 | 44 |
2021 | 22 | 20 | 42 |
2022 | 2 | 28 | 30 |
2023 | 2 | 27 | 29 |
2024 | 3 | 6 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence. Clin Cancer Res. 2024 Apr 01; 30(7):1232-1239.
-
Plain Language Summary: Immunotherapy for Inhalant Allergy. Otolaryngol Head Neck Surg. 2024 Mar; 170(3):668-674.
-
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal. Eur J Cancer. 2024 Apr; 201:113972.
-
Therapeutic synthetic and natural materials for immunoengineering. Chem Soc Rev. 2024 Feb 19; 53(4):1789-1822.
-
Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS Nano. 2024 Feb 13; 18(6):5152-5166.
-
Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy. J Immunol. 2024 01 15; 212(2):188-198.
-
Immunoengineering a Future of Molecular, Material, and Cellular Therapeutics. J Immunol. 2024 01 15; 212(2):167-168.
-
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. J Exp Clin Cancer Res. 2024 Jan 02; 43(1):6.
-
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jan 01; 10(1):32-41.
-
Melanoma and microbiota: Current understanding and future directions. Cancer Cell. 2024 01 08; 42(1):16-34.